Simplex Trading’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,779
| Closed | -$229K | – | 11957 |
|
|
2021
Q3 | $229K | Hold |
1,779
| – | – | ﹤0.01% | 5381 |
|
|
2021
Q2 | $223K | Sell |
1,779
-6,182
| -78% | -$780K | ﹤0.01% | 5520 |
|
|
2021
Q1 | $1.08M | Buy |
7,961
+6,669
| +516% | +$861K | ﹤0.01% | 2308 |
|
|
2020
Q4 | $165K | Buy |
1,292
+880
| +214% | +$103K | ﹤0.01% | 4863 |
|
|
2020
Q3 | $46K | Sell |
412
-7,519
| -95% | -$749K | ﹤0.01% | 5692 |
|
|
2020
Q2 | $755K | Buy |
7,931
+7,181
| +957% | +$692K | ﹤0.01% | 2412 |
|
|
2020
Q1 | $67K | Buy |
750
+75
| +11% | +$5.83K | ﹤0.01% | 4833 |
|
|
2019
Q4 | $35K | Buy |
+675
| New | +$30.8K | ﹤0.01% | 5539 |
|
|
2019
Q3 | – | Sell |
-4,826
| Closed | -$209K | – | 8156 |
|
|
2019
Q2 | $198K | Sell |
4,826
-9,174
| -66% | -$380K | ﹤0.01% | 3474 |
|
|
2019
Q1 | $651K | Buy |
14,000
+12,598
| +899% | +$553K | ﹤0.01% | 2385 |
|
|
2018
Q4 | $61K | Sell |
1,402
-1,086
| -44% | -$54.3K | ﹤0.01% | 4346 |
|
|
2018
Q3 | $142K | Sell |
2,488
-16,366
| -87% | -$804K | ﹤0.01% | 4044 |
|
|
2018
Q2 | $914K | Buy |
18,854
+17,356
| +1,159% | +$632K | ﹤0.01% | 1882 |
|
|
2018
Q1 | $58K | Buy |
+1,498
| New | +$63.7K | ﹤0.01% | 2298 |
|
|
2017
Q4 | – | Sell |
-10,787
| Closed | -$405K | – | 6987 |
|
|
2017
Q3 | $402K | Buy |
+10,787
| New | +$374K | 0.02% | 783 |
|
|
2017
Q2 | – | Sell |
-4,281
| Closed | -$124K | – | 7083 |
|
|
2017
Q1 | $113K | Buy |
4,281
+2,438
| +132% | +$64.3K | ﹤0.01% | 1648 |
|
|
2016
Q4 | $47K | Buy |
+1,843
| New | +$58.4K | ﹤0.01% | 2224 |
|
|
2016
Q2 | – | Sell |
-1,132
| Closed | -$36.8K | – | 6689 |
|
|
2016
Q1 | $29K | Sell |
1,132
-2,205
| -66% | -$64.1K | ﹤0.01% | 2465 |
|
|
2015
Q4 | $162K | Sell |
3,337
-6,515
| -66% | -$234K | 0.01% | 1026 |
|
|
2015
Q3 | $245K | Buy |
+9,852
| New | +$296K | 0.02% | 795 |
|
|
2015
Q2 | – | Sell |
-2,175
| Closed | -$70.2K | – | 6090 |
|
|
2015
Q1 | $82K | Sell |
2,175
-11,427
| -84% | -$454K | 0.01% | 1220 |
|
|
2014
Q4 | $530K | Buy |
+13,602
| New | +$474K | 0.06% | 258 |
|
Simplex Trading's XLRN Position: Q4 2021 in Review
Simplex Trading sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,779 shares — an estimated $229K sold.
Simplex Trading first reported a position in XLRN in Q4 2014 and held it in 22 quarters. The position peaked at $1.08M in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Simplex Trading reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Simplex Trading sold 1,779 Acceleron Pharma shares in Q4 2021, an estimated $229K.
- Simplex Trading first reported a position in Acceleron Pharma in Q4 2014 and held it in 22 quarters.
- Simplex Trading's Acceleron Pharma position peaked at $1.08M in Q1 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Simplex Trading's 13F filing for Q4 2021, filed 4 Feb 2022.